Today: 17 March 2026
Subscribe
Browse Category

NASDAQ:STOK 24 February 2026

Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics shares dropped 1.2% to $35.80 in early premarket trading Tuesday, after a 5.7% gain the previous session. Wolfe Research began coverage with an “Outperform” rating and a $40 price target. Investors are watching for updates on the company’s Phase 3 Dravet syndrome trial with Biogen. About 21.6% of Stoke’s float is sold short, according to MarketBeat.
24 February 2026
···

Stock Market Today

  • NORMA Group (NOEJ) Shares Drop 1.9% Amid Lower Trading Volume
    March 17, 2026, 12:46 AM EDT. Shares of NORMA Group SE (ETR:NOEJ) fell 1.9% to €14.66 in mid-day trading on Monday, hitting a low of €14.58. Trading volume was down 50% from average, with 50,112 shares changing hands compared to the usual 99,678. The company, with a market cap of $479.39 million, has a price-to-earnings ratio of 20.59 and a beta of 1.07, indicating moderate volatility relative to the market. NORMA Group manufactures engineered joining technology solutions sold globally under various brand names. Despite the dip, analysts currently rate the stock as Hold. MarketBeat notes other stocks command stronger analyst recommendations.
Go toTop